HEV 239 vaccine induces durable humoral and cellular immunity in Bangladeshi women
Hepatitis E vaccine shows durable immunity in women
This longitudinal cohort study in 1480 women aged 16-39 years in Bangladesh found that HEV 239 (Hecolin) vaccination led to significantly hi…
A hepatitis E vaccine kept women protected for up to 3 years, with stronger immune memory than a comparison group.
Hepatitis E vaccine linked to elevated spontaneous abortion risk when given 31-60 days before pregnancy
A Vaccine's Hidden Risk Window for Early Pregnancy Loss
An RCT in women vaccinated during or shortly before pregnancy found an elevated risk of spontaneous abortion (Relative Risk 4.3) in HEV239 r…
A Hepatitis E vaccine given one to two months before pregnancy is linked to a higher risk of miscarriage, forcing doctors to rethink timing …
Namibia reports first nationwide hepatitis E outbreak concentrated in informal settlements
Why is hepatitis E spreading across Namibia for the first time?
A field report describes Namibia's first nationwide hepatitis E outbreak, which was protracted and concentrated in informal settlements with…
Namibia faces its first nationwide hepatitis E outbreak, spreading mainly in informal settlements where poor water and sanitation create per…